Jennifer Chan, MD, MPH, discussed the recent FDA approval of cabozantinib in pancreatic and extrapancreatic neuroendocrine tumors.

The approval came on the bases of the results from the phase 3 CABINET study. The study compared cabozantinib to a placebo in ...

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...

While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...

Primary neuroendocrine carcinoma of the male breast is an exceptionally rare entity, with fewer than 50 cases documented in ...

The FDA has completed its review of the investigational new drug application (IND) for PSV359, and issued a "study may proceed” letter in 1Q 2025. Site activation activities are underway, with the ...

Increasing cancer prevalence, including prostate cancer and neuroendocrine tumors, advances in nuclear medicine in the field ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

Years ago, a family member was diagnosed with an extremely rare cancer: Liposarcoma of the Spermatic Cord. Fewer than 200 cases have been reported worldwide, making this diagnosis both a blessing and ...

Teddi Mellencamp’s doctors discovered more tumors in her body after she underwent emergency brain surgery last month. The "Real Housewives of Beverly Hills" star shared a health update on her ...

"These are all a direct result of my melanoma,” the podcast host wrote in a Thursday, March 6 Instagram post Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023.